Application no. and date | 15864826.1 (espacenet) (Federated) (European Patent Register), 20151204 | Patent/reg. no. and date | DK/EP 3227432, 20231011 | Publication date | 20171011 | Priority no. and date | US 201462088309 P, 20141205 | EP pub. no. and date |
EP 3227432 20171011 | Effective date | | Applicant/owner | Eureka Therapeutics, Inc., 5858 Horton Street, Suite 362
Emeryville, CA 94608, US, Memorial Sloan Kettering Cancer Center, 1275 York Avenue
New York, NY 10065, US | Applicant ref. no. | SUNQ/P87900DK | Inventor | BRENTJENS, Renier, J., 1275 York Avenue
New York, NY 10021, US, SMITH, Eric, L., 1275 York Avenue
New York, NY 10021, US, LIU, Cheng, 4 Commodore Drive D334
Emeryville, CA 94608, US | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 1550 København V, DK | Opponent | | IPC Class | A61K 35/17 (2015.01) , A61P 35/00 (2006.01) , C07K 14/705 (2006.01) , C07K 14/725 (2006.01) , C07K 16/28 (2006.01) | Title | CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND USES THEREOF | Int. application no. | US2015064112 | Int. publication no. | WO2016090320 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|